CHERYL MOORE, president and chief operating officer of the New York Genome Center (NYGC), has been named director of research programs for the UK-based Wellcome Trust. Prior to joining NYGC, Moore held leadership posts at the Howard Hughes Medical Institute, one of the biggest philanthropic medical research funders in the U.S. She is, in addition, a member of the governing boards of the Sainsbury Wellcome Centre for Neural Circuits and Behaviour and of Genome Research Ltd, the parent company of the Wellcome Sanger Institute and Wellcome Genome Campus.
JAY KIM has been named the new executive director of the Foundation for MetroWest in Natick Massachusetts. Kim, the foundation's chief operating officer, will succeed JUDY SALERNO, who is retiring after fifteen years. Before joining the foundation in 2017, Kim led fundraising and development work for nonprofit organizations in the greater Boston area, including stints at the Boston Foundation and in corporate philanthropy at Target Corp; managed homelessness initiatives at the Fannie Mae Foundation; and worked for Public Allies, a national AmeriCorps program. He began his career as a corps member at City Year Boston.
The Indianapolis-based Lilly Endowment has announced that ELYSSA CAMPODONICO-BARR and LEAH SEIGEL are joining its staff as program directors in community development. Campodonico-Barr comes to the endowment from Girls Inc. of Greater Indianapolis, which she has served as president and CEO since May 2018. Previously, she worked as chief of staff for the Indiana Bureau of Motor Vehicles and at Indiana University in the Office of the Vice President and General Counsel. Seigel joins the endowment after a legal career with the firm Barnes and Thornburg. Her extensive experience includes service on the boards of nonprofit organizations, including the Indiana Coalition Against Domestic Violence and Happy Hollow Children’s Camp.
The Harry and Jeanette Weinberg Foundation in Owings Mills, Maryland, has announced the promotion of DAVID GILMORE to the role of deputy chief investment officer. Since joining the foundation in 2014, Gilmore has served as managing director of investments. In his new role, he will support Chief Investment Officer Jonathan Hook, who will continue to serve in that role, and will assume additional team leadership responsibilities while maintaining focus on investment manager diversity and due diligence, asset allocation, and risk management.
The John Templeton Foundation in Conshohocken, Pennsylvania, has announced BRIAN CRAWFORD as director, investments. In that role, Crawford, who previously worked as managing director and senior consultant at Crewcial Partners, LLC in New York City, will assist with the foundation in achieving its financial goals and adhering to the investment mandate set out by its founder, Sir John Templeton. Crawford has worked in the financial services industry for more than twenty-five years and, prior to joining Crewcial, served as a research manager at Bank of America and as a research analyst at Asset Consulting Group.
The Newman’s Own Foundation in Westport, Connecticut, has announced the appointment of BRIDGETTE HELLER to its board of directors. An accomplished leader of consumer businesses, Heller most recently served as the EVP and president of Nutricia, the Specialized Nutrition Division of Danone, and previously led businesses and business units at Merck Consumer Care, Johnson & Johnson, Chung’s Gourmet Foods, and Kraft Foods. She currently serves on the boards of Newman’s Own, Inc., Aramark, Novartis, Dexcom, and the nonprofit Preserve Vision Florida and is a member of the advisory board for the Kellogg School of Management.
In other news, KEVIN J. FOYLE, MBA, CFRE, has been named chair of the Association of Fundraising Professionals Global, the largest organization of charitable fundraisers in the world, succeeding MARTHA SCHUMAKER, CFRE, ACFRE, MinstF, who served as chair in 2019 and 2020 and will step into the role of immediate past chair. Foyle has nearly twenty years of development experience in the Houston community and currently serves as vice president of development and public affairs for the University of Texas Health Science Center at Houston (UTHealth), where he is responsible for all aspects of UTHealth’s development program, including principal, planned, major and annual gifts, corporate and foundation relations and administrative and information services.
And the Seattle-based Allen Institute, an independent 501(c)(3) nonprofit medical research organization founded by the late Paul G. Allen, has announced that founding CEO ALLAN JONES, PhD, will be stepping down after nearly eighteen years with the organization. Jones joined the institute in its planning stages in 2003, was promoted the next year to lead its science mission, and was named its first chief executive officer in 2010. Reflecting on Jones’ contributions, Jody Allen said, “When [Paul and I] created the Allen Institute, we knew it would take a bold and courageous leader to guide and grow the organization, bringing together some of the world’s best scientists in pursuit of impact at scale. Allan shared that vision from the beginning and brought many years of consistent and strong leadership, for which we are all extremely grateful. His passion for the work and commitment to the Institute’s mission will surely inspire new discoveries in our next chapter.” Jones will continue to serve as president and CEO until his successor is named, at which time he will join the institute’s board of directors and will be honored with the title president-emeritus.